The right of privacy in choosing medical treatment: should terminally ill persons have access to drugs not yet approved by the Food and Drug Administration?

نویسنده

  • Scott H Power
چکیده

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

An analysis of common ethical justifications for compassionate use programs for experimental drugs

BACKGROUND When a new intervention or drug is developed, this has to pass through various phases of clinical testing before it achieves market approval, which can take many years. This raises an issue for drugs which could benefit terminally ill patients. These patients might set their hopes on the experimental drug but are unable to wait since they are likely to pass away before the drug is av...

متن کامل

Who Stands to Benefit? Right to Try Law Provisions and Implications

As of late November 2016, 32 states had adopted right to try laws. These laws are intended to allow terminally ill patients preapproval, or “compassionate,” access to drugs, devices, or biologics that are in development and have not yet been approved by the United States Food and Drug Administration (FDA). While the laws’ intentions and their impact have been examined, little has been written a...

متن کامل

A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.

In 2008, it was estimated that 565,650 Americans would die of cancer, accounting for one of every four deaths in the United States. Doctors expected to diagnose 1,437,180 new patients with cancer throughout 2008, bringing the U.S. cancer population to over ten million. While many of the cancers diagnosed are curable or manageable, others continue to remain deadly. These terminally ill patients ...

متن کامل

A Review of Pharmacotherapy for Coronavirus Disease 2019 (COVID-19)

The epidemic of COVID-19 and its associated acute respiratory syndrome has posed an unprecedented challenge in identifying effective drugs to prevent and treat it. Due to the high prevalence of this disease and the high number of people at risk, medical staff needs accurate evidence regarding effective drug treatments for this infection. There is currently no effective treatment for COVID-19. B...

متن کامل

Taking Psychedelics Seriously

BACKGROUND Psychiatric research in the 1950s and 1960s showed potential for psychedelic medications to markedly alleviate depression and suffering associated with terminal illness. More recent published studies have demonstrated the safety and efficacy of psilocybin, MDMA, and ketamine when administered in a medically supervised and monitored approach. A single or brief series of sessions often...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The John Marshall law review

دوره 20 4  شماره 

صفحات  -

تاریخ انتشار 1987